Ergomed’s Meticulous Risk-Based Quality Management Approach

As a pioneer in providing comprehensive support for your clinical research, Ergomed champions an innovative Risk-Based Quality Management (RBQM) approach. This forward-thinking strategy ensures the highest patient safety standards, regulatory compliance, and data reliability. Ergomed’s proactive approach to managing clinical trials tackles clinical research complexity head-on.

The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.

Biostatistical services, including SAP development, statistical programming in SAS, analysis, submission-ready services and statistical reports are customized and designed specifically to meet your project requirements.

TrialKit requires minimal training for quick deployment. Its open API integrates seamlessly with databases, ideal for fast patient registry studies and high-quality data.

Navigating drug safety in the era of innovation-driven medicine

The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.

Streamline clinical trial data capture through eSource workflows that support both Direct Data Capture and automated EHR-to-EDC data transfer across Paradigm Health’s research-ready provider network.

Research teams can capture study data within the EHR or through a standalone application, enabling consistent workflows across sites while reducing manual transcription. Sponsors gain faster access to cleaner trial data with fewer queries and more efficient monitoring.

Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.

Identify & engage healthcare professionals (HCP) treating eligible patients—in near real-time

Timely physician engagement is critical to therapy adoption. Quest Diagnostics combines near real-time lab data with other data sources including EHR, claims and prescription data to help pharmaceutical teams identify and connect with physicians managing eligible patients at key decision time point in the patient journey.

In today’s competitive pharmaceutical landscape, ensuring that physicians receive timely, relevant information about new therapies is essential. Quest’s unique combination of industry-leading deidentified lab data, enhanced with claims, prescription (Rx), and EHR insights, allows pharma teams to refine targeting, optimize engagement, and drive better patient outcomes.